NCT05897086View on ClinicalTrials.gov

Polyethylene-glycol Assisted Nerve Repair in Phalloplasty

PHASE2/PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

December 30, 2028

Study Completion Date

December 1, 2029

Conditions
Gender Dysphoria
Interventions
DRUG

Polyethylene Glycol 3350

Topical irrigation with approximately 2 ccs of a 190 mM solution of 50% PEG 3.35 kD in sterile water

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER